PL2971005T3 - Ulepszona ekspresja rekombinowanego białka z zastosowaniem hybrydowego promotora CHEF1 - Google Patents

Ulepszona ekspresja rekombinowanego białka z zastosowaniem hybrydowego promotora CHEF1

Info

Publication number
PL2971005T3
PL2971005T3 PL14727377T PL14727377T PL2971005T3 PL 2971005 T3 PL2971005 T3 PL 2971005T3 PL 14727377 T PL14727377 T PL 14727377T PL 14727377 T PL14727377 T PL 14727377T PL 2971005 T3 PL2971005 T3 PL 2971005T3
Authority
PL
Poland
Prior art keywords
hybrid
protein expression
recombinant protein
improved recombinant
chef1 promoter
Prior art date
Application number
PL14727377T
Other languages
English (en)
Inventor
Howard R. Clarke
Original Assignee
Agc Biologics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agc Biologics, Inc. filed Critical Agc Biologics, Inc.
Publication of PL2971005T3 publication Critical patent/PL2971005T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
PL14727377T 2013-03-12 2014-03-11 Ulepszona ekspresja rekombinowanego białka z zastosowaniem hybrydowego promotora CHEF1 PL2971005T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361777603P 2013-03-12 2013-03-12
PCT/US2014/023661 WO2014164869A1 (en) 2013-03-12 2014-03-11 Improved recombinant protein expression using a hybrid chef1 promoter
EP14727377.5A EP2971005B1 (en) 2013-03-12 2014-03-11 Improved recombinant protein expression using a hybrid chef1 promoter

Publications (1)

Publication Number Publication Date
PL2971005T3 true PL2971005T3 (pl) 2020-12-14

Family

ID=50846904

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14727377T PL2971005T3 (pl) 2013-03-12 2014-03-11 Ulepszona ekspresja rekombinowanego białka z zastosowaniem hybrydowego promotora CHEF1

Country Status (18)

Country Link
US (4) US9297024B2 (pl)
EP (2) EP2971005B1 (pl)
KR (1) KR102365484B1 (pl)
CN (2) CN110042122A (pl)
AU (1) AU2014248936B2 (pl)
CA (1) CA2904125C (pl)
CY (1) CY1123336T1 (pl)
DK (1) DK2971005T3 (pl)
ES (1) ES2811648T3 (pl)
HR (1) HRP20201442T1 (pl)
HU (1) HUE050362T2 (pl)
LT (1) LT2971005T (pl)
NZ (1) NZ711654A (pl)
PL (1) PL2971005T3 (pl)
PT (1) PT2971005T (pl)
SI (1) SI2971005T1 (pl)
SM (1) SMT202000537T1 (pl)
WO (1) WO2014164869A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2904125C (en) * 2013-03-12 2022-06-07 Cmc Icos Biologics, Inc. Improved recombinant protein expression using a hybrid chef1 promoter
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
EP3356543A4 (en) 2015-09-28 2019-05-29 The Trustees of Columbia University in the City of New York MODIFIED BACTERIAL PROTEIN EXPRESSION SYSTEM
GB201603577D0 (en) 2016-03-01 2016-04-13 Oxford Genetics Ltd Promoter
CN107043773B (zh) * 2017-02-08 2018-09-18 四川丰讯科技发展有限公司 一种提高哺乳动物细胞中外源基因表达水平的基因片段、重组载体及其用途
US11713468B2 (en) 2017-08-02 2023-08-01 Dna Twopointo Inc. DNA vectors and elements for sustained gene expression in eukaryotic cells
AU2019206443A1 (en) * 2018-01-10 2020-07-23 Cmc Icos Biologics, Inc. Bidirectional CHEFl vectors
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium
WO2024149284A1 (en) * 2023-01-10 2024-07-18 Nanjing Legend Biotech Co., Ltd. Regulatory sequences and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888809A (en) * 1997-05-01 1999-03-30 Icos Corporation Hamster EF-1α transcriptional regulatory DNA
DK1492874T3 (da) * 2002-03-29 2011-03-14 Xoma Technology Ltd Multigene vektorplasmider og fremgangsmåder til forøgelse af ekspressionen af rekombinante polypeptider
KR100533794B1 (ko) 2003-10-02 2005-12-07 주식회사 프로젠 인간 난포자극 호르몬을 대량으로 생산하는 방법
CA2590284A1 (en) * 2004-12-08 2006-06-15 Icos Corporation Recombinant method for making multimeric proteins
PL1969127T5 (pl) * 2005-12-21 2018-02-28 Cnj Holdings, Inc Metoda wytwarzania biologicznie czynnych białek zależnych od witaminy K metodami rekombinacji
WO2007081336A1 (en) * 2006-01-13 2007-07-19 Five Prime Therapeutics, Inc. Mammalian vectors for high-level expression of recombinant proteins
CA2656558A1 (en) * 2006-06-30 2008-01-10 The Regents Of The University Of Michigan Method of producing factor viii proteins by recombinant methods
NZ598275A (en) * 2009-08-06 2014-11-28 Cmc Icos Biolog Inc Methods for improving recombinant protein expression
WO2012052878A1 (en) 2010-10-19 2012-04-26 Vascular Biogenics Ltd. Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
CA2904125C (en) * 2013-03-12 2022-06-07 Cmc Icos Biologics, Inc. Improved recombinant protein expression using a hybrid chef1 promoter

Also Published As

Publication number Publication date
US20210340560A1 (en) 2021-11-04
WO2014164869A1 (en) 2014-10-09
HUE050362T2 (hu) 2020-11-30
KR102365484B1 (ko) 2022-02-18
KR20150126399A (ko) 2015-11-11
AU2014248936A1 (en) 2015-09-24
PT2971005T (pt) 2020-09-01
US20140273208A1 (en) 2014-09-18
US20160177335A1 (en) 2016-06-23
US9297024B2 (en) 2016-03-29
CA2904125C (en) 2022-06-07
CN105209625A (zh) 2015-12-30
HRP20201442T1 (hr) 2020-12-11
AU2014248936B2 (en) 2020-07-09
ES2811648T3 (es) 2021-03-12
US20190071691A1 (en) 2019-03-07
US9957525B2 (en) 2018-05-01
DK2971005T3 (da) 2020-08-24
HK1220491A1 (en) 2017-05-05
CN110042122A (zh) 2019-07-23
EP2971005A1 (en) 2016-01-20
SI2971005T1 (sl) 2020-10-30
NZ711654A (en) 2021-07-30
EP2971005B1 (en) 2020-06-17
SMT202000537T1 (it) 2020-11-10
CY1123336T1 (el) 2021-12-31
EP3770263A1 (en) 2021-01-27
CA2904125A1 (en) 2014-10-09
LT2971005T (lt) 2020-10-12
CN105209625B (zh) 2019-03-29

Similar Documents

Publication Publication Date Title
SI2822577T1 (sl) Rekombinantni proteini faktorja VIII
EP2839019A4 (en) CD3 BINDING POLYPEPTIDES
SMT202000537T1 (it) Espressione aumentata di una proteina ricombinante mediante l'uso di un promotore ibrido chef1
SG11201504883PA (en) Peptides as oxytocin agonists
PT2964775T (pt) Promotores de leveduras para a expressão proteica
EP3033098A4 (en) Recombinant factor viii proteins
ZA201406434B (en) Improved harvest operations for recombinant proteins
ZA201600729B (en) Peptides
EP2971035A4 (en) RECOMBINED POLYPEPTIDE PRODUCTION
GB201304973D0 (en) Recombinant protein
ZA201503127B (en) Peptides
SG10201507721SA (en) CHO-GMT Recombinant Protein Expression
GB201204868D0 (en) Peptides
GB201315130D0 (en) Peptides
GB2534804B (en) Hybrid controls architecture
GB2526222B (en) Viral peptides
IL235840A0 (en) Alternaria peptides
SG11201504096RA (en) Recombinant protein
GB201210286D0 (en) Recombinant polypeptide
GB201300529D0 (en) Recombinant polypeptide
GB201316660D0 (en) Peptides
GB201300381D0 (en) Peptides
GB201305465D0 (en) Novel peptides
GB201204065D0 (en) Fusion polypeptide
GB201200509D0 (en) Peptides